SCHEMBL7540594

SCHEMBL7540594

c1ccc(CN2CCC(CN3CCc4ccccc4C3)CC2)cc1

nearest known ligand 0.76

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.76
SIGMAR1 Q99720 3/20 0.60
HTR1A P08908 2/20 0.60
PRMT5 O14744 2/20 0.57
WDR77 Q9BQA1 2/20 0.57
CCR3 P51677 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10415385 0.99 ACHE (0.74) ACHESIGMAR1HTR1APRMT5WDR77
Hydrochloric Acid SCHEMBL9633667 0.90 ACHE (0.64) ACHESIGMAR1HTR1ACCR3
SCHEMBL10483079 0.89 MAPT (0.62) ACHESIGMAR1HTR1APRMT5WDR77
SCHEMBL10415375 0.86 ACHE (0.58) ACHESIGMAR1HTR1APRMT5WDR77
SCHEMBL38653916 0.85 DRD2 (0.59) ACHEPRMT5WDR77
SCHEMBL10416145 0.83 ACHE (0.55) ACHESIGMAR1HTR1APRMT5WDR77
Fumaric Acid SCHEMBL10415402 0.83 ACHE (0.55) ACHE
Fumaric Acid SCHEMBL10414747 0.83 ACHE (0.55) ACHE
SCHEMBL31134754 0.83 ACHE (0.66) ACHESIGMAR1PRMT5WDR77
SCHEMBL10978742 0.83 ACHE (0.66) ACHESIGMAR1PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173170-A4 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO INC (US) 2002-05-29 EP disclosed
EP-1173170-A1 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Merck & Co., Inc. (US) 2002-01-23 EP disclosed
US-6265434-B1 ANTIINFLAMMATORY AGENTS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000059503-A1 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-10-12 WO disclosed